Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

Autor: Bamford, A., Turkova, A., Lyall, H., Foster, C., Klein, N., Bastiaans, D., Burger, D., Bernadi, S., Butler, K., Chiappini, E., Clayden, P., Della Negra, M., Giacomet, V., Giaquinto, C., Gibb, D., Galli, L., Hainaut, M., Koros, M., Marques, L., Nastouli, E., Niehues, T., Noguera-Julian, A., Rojo, P., Rudin, C., Scherpbier, H. J., Tudor-Williams, G., Welch, S. B.

Publikováno v: HIV MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
HIV medicine, 19(1), e1-e42. Wiley-Blackwell
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
HIV Medicine
HIV medicine, 19 (1

The 2015 Paediatric European Network for Treatment of AIDS (PENTA) guidelines provide practical recommendations on the management of HIV-1 infection in children in Europe and are an update to those published in 2009. Aims of treatment have progressed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::da12839e10ac66f6c0ffd5f1fc48f227
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7422

Natural killer cell-based cancer immunotherapy: from basics to clinical trials.

Autor: Shi, Yinghong^1,2 (AUTHOR), Hao, Donglin¹ (AUTHOR) haodonglin9@sina.com, Qian, Hui^1,2 (AUTHOR) lstmmmlst@163.com, Tao, Zhimin^1,2,3 (AUTHOR) jsutao@ujs.edu.cn

Publikováno v: Experimental Hematology & Oncology. 10/16/2024, Vol. 13 Issue 1, p1-26. 26p.

Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation.

Autor: Graczyk-Pol E; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Rogatko-Koros M; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Nestorowicz K; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Gwozdowicz S; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Mika-Witkowska R; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Pawliczak D; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Zubala M; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Szlendak U; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Witkowska A; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Tomaszewska A; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Nasilowska-Adamska B; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Szczepinski A; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Wojcik M; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Halaburda K; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Nowak J; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

Publikováno v: HLA [HLA] 2018 Dec; Vol. 92 Suppl 2, pp. 42-46.

HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.

Autor: Nowak J; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. Electronic address: jnowak@ihit.waw.pl., Nestorowicz K; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Graczyk-Pol E; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Mika-Witkowska R; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Rogatko-Koros M; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Jaskula E; Department of Clinical Immunology, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland; Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry, Wrocław, Poland., Koscinska K; Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry, Wrocław, Poland., Madej S; Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry, Wrocław, Poland., Tomaszewska A; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Nasilowska-Adamska B; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Szczepinski A; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Halaburda K; Department of Hematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Dybko J; Department of Hematology, Blood Malignancies and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Kuliczkowski K; Department of Hematology, Blood Malignancies and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Czerw T; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Holowiecki J; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland., Baranska M; Department of Oncology Hematology and Paediatric Transplantology, Poznan University of Medical Sciences, Poznan, Poland., Pieczonka A; Department of Oncology Hematology and Paediatric Transplantology, Poznan University of Medical Sciences, Poznan, Poland., Wachowiak J; Department of Oncology Hematology and Paediatric Transplantology, Poznan University of Medical Sciences, Poznan, Poland., Czyz A; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland., Gil L; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland., Lojko-Dankowska A; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland., Komarnicki M; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland., Bieniaszewska M; Department of Hematology and Transplantology, Gdansk Medical University Clinical Center, Gdansk, Poland., Kucharska A; Department of Hematology and Transplantology, Gdansk Medical University Clinical Center, Gdansk, Poland., Hellmann A; Department of Hematology and Transplantology, Gdansk Medical University Clinical Center, Gdansk, Poland., Gronkowska A; Department of Hematology, Oncology and Internal Medicine, Warsaw Medical University, Warsaw, Poland., Jedrzejczak WW; Department of Hematology, Oncology and Internal Medicine, Warsaw Medical University, Warsaw, Poland., Markiewicz M; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland., Koclega A; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland., Kyrcz-Krzemien S; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland., Mielcarek M; Department of Pediatric Hematology Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Kalwak K; Department of Pediatric Hematology Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Styczynski J; Department of Pediatric Hematology and Oncology, Collegium Medicum Nicolaus Copernicus University Hospital, Bydgoszcz, Poland., Wysocki M; Department of Pediatric Hematology and Oncology, Collegium Medicum Nicolaus Copernicus University Hospital, Bydgoszcz, Poland., Drabko K; Department of Paediatric Hematology, Oncology and Transplantology, Medical University, Lublin, Poland., Wojcik B; Department of Paediatric Hematology, Oncology and Transplantology, Medical University, Lublin, Poland., Kowalczyk J; Department of Paediatric Hematology, Oncology and Transplantology, Medical University, Lublin, Poland., Gozdzik J; Department of Transplantation Children's University Hospital, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Cracow, Poland., Pawliczak D; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Gwozdowicz S; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Dziopa J; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Szlendak U; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Witkowska A; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Zubala M; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Gawron A; Department of Immunogenetics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Warzocha K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Lange A; Department of Clinical Immunology, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland; Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry, Wrocław, Poland.

Publikováno v: Human immunology [Hum Immunol] 2018 Jun; Vol. 79 (6), pp. 403-412. Date of Electronic Publication: 2018 Mar 29.

„License to kill” – hamujące receptory KIR mogą zwiększać zdolność komórek NK do niszczenia komórek nowotworu w odpowiednim środowisku HLA klasy I u biorców przeszczepu krwiotwórczych komórek macierzystych

Autor: Nowak, J., Kościńska, K., Mika-Witkowska, R., Rogatko-Koroś, M., Jaskuła, E., Mordak-Domagała, M., Lange, J., Gronkowska, A., Jędrzejczak, W.W., Kyrcz-Krzemień, S., Markiewicz, M., Dzierżak-Mietła, M., Tomaszewska, A., Nasiłowska-Adamska, B., Szczepiński, A., Hałaburda, K., Hellmann, A., Komarnicki, M., Gil, L., Czyż, A., Wachowiak, J., Barańska, M., Kowalczyk, J., Drabko, K., Goździk, J., Bogunia-Kubik, K., Wysoczańska, B., Graczyk-Pol, E., Witkowska, A., Marosz-Rudnicka, A., Nestorowicz, K., Dziopa, J., Szlendak, U., Warzocha, K., Lange, A.

Publikováno v: In Acta Haematologica Polonica September 2015 46 Supplement 1:186-186